Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2130-2025

SIGNA Architect Recall

SIGNA Architect

FDA recall Class II

Ongoing

FDA lists this Class II recall for SIGNA Architect. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2130-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 23, 2025
FDA report date
Jul 30, 2025
Quantity in commerce
N/A
Distribution
See key details
FDA cause
Device Design

What is being recalled?

SIGNA Architect

Affected model & UDI checker

Search the exact identifiers published for Z-2130-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedSIGNA ArchitectCheck source notice00840682147095
Not specifiedSIGNA ArchitectCheck source notice00840682122702
Not specifiedSIGNA ArchitectCheck source notice00195278023643
Not specifiedSIGNA ArchitectCheck source notice00840682123440
FDA code information

GTIN: 00840682147095 00840682122702 00195278023643 00840682123440

View the original FDA recall notice

Why was this product recalled?

GE HealthCare has become aware that gradient coils for certain MR systems (see affected product list in this letter), under specific conditions, can produce elevated acoustic noise during scanning. As a result, acoustic levels can exceed 99dB, the limit established by International Electrotechnical Commission (IEC 60601-2-33) when using hearing protection with a Noise Reduction Rating (NRR) of 29dB, as currently required in the Operator Manual.

What actions did GE Medical Systems, LLC take?

GE Healthcare issued an URGENT MEDICAL DEVICE CORRECTION to its consignees on 05/23/2025 delivered using traceable means. The notice explained the issue, risk, and requested the following: Actions to be taken by Customer/User: You can continue to use your MR system by following the instructions below: Ensure hearing protection with a Noise Reduction Rating (NRR) of at least 33dB is used during exams on these systems. 200 pairs are provided with this letter. Please post this letter in your facility on or near the MR operator console. Please ensure all potential users in your facility are made aware of this safety notification and the recommended actions. Please retain this document for your records. Please complete and return the attached acknowledgement form to [email protected].

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology